Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

anti-BCMA autologous CAR-T cells (CT053) receives US FDA orphan drug designation

biospectrumasiaSeptember 03, 2019

Tag: anti-BCMA , FDA , Orphan Drug

PharmaSources Customer Service